Exploring the Correlation Between Splenomegaly and Lung Involvement in COVID-19: A Retrospective Study

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Apr 3

PMID 38567206

Authors

Bharathi Priya Raju

Balaji Selvaraj

Sharmila Murugesan

Suhasini Balasubramaniam

Sowmiya Pk

Pravin Kumar Raviganesh

Rajasekaran Sivaprakasam

Sangeetha Balaji

Rupert Nithin Fernando

Swaminathan Ramasubramanian

Affiliations

Soon will be listed here.

Abstract

Background Coronavirus disease 2019 (COVID-19), resulting from the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), has not only shown substantial effects on the respiratory system but also on extrapulmonary systems, including cardiovascular, gastrointestinal, hematological, and immune responses, notably spleen enlargement. The connection between the enlargement of the spleen and pulmonary complications in individuals with COVID-19 is still not well elucidated, with current studies offering divergent conclusions. Objective This study aims to elucidate the correlation between splenomegaly, as assessed by computed tomography (CT) imaging, and the extent of lung involvement (LI) in COVID-19 patients, thereby offering insights into potential prognostic indicators. Methodology A hospital-based, cross-sectional, retrospective study was conducted involving 1058 symptomatic COVID-19 patients confirmed by reverse transcriptase-polymerase chain reaction (RT-PCR), aged 18 years and above. CT imaging was utilized to evaluate spleen size and LI. Statistical analyses, including Pearson correlation and simple linear regression, were performed to explore the relationship between spleen size and LI. Results The study cohort exhibited a mean spleen size of 9.49 cm and a mean LI score of 0.272. The Pearson correlation coefficient was calculated at 0.0495, indicating a marginal positive correlation between spleen size and LI. Regression analysis demonstrated a minimal impact of spleen size on LI, with spleen size accounting for only 0.2% of the variance in LI scores. Conclusions The study found a slight, statistically non-significant correlation between splenomegaly and LI in COVID-19 patients, suggesting that while splenic enlargement may reflect systemic disease involvement, it is not a strong independent predictor of lung damage extent. The findings highlight the complexity of extrapulmonary manifestations and highlight the need for additional research to fully understand the implications of splenic involvement in COVID-19.

References

Xie L, Lin Y, Deng Y, Lei B . The Effect of SARS-CoV-2 on the Spleen and T Lymphocytes. Viral Immunol. 2021; 34(6):416-420. DOI: 10.1089/vim.2020.0320. View

Indiran V, Vinod Singh N, Prasad T, Maduraimuthu P . Does coronal oblique length of spleen on CT reflect splenic index?. Abdom Radiol (NY). 2017; 42(5):1444-1448. DOI: 10.1007/s00261-017-1055-1. View

Aksu Y, Uslu A, Tarhan G, Karagulle M, Tiryaki S . The Relationship among Splenomegaly, Lung Involvement Patterns, and Severity Score in COVID-19 Pneumonia. Curr Med Imaging. 2022; 18(12):1311-1317. DOI: 10.2174/1573405618666220509212035. View

Robertson F, Leander P, Ekberg O . Radiology of the spleen. Eur Radiol. 2001; 11(1):80-95. DOI: 10.1007/s003300000528. View

Kablawi D, Alhinai A, Wong P, Deschenes M, Sebastiani G, Benmassaoud A . Splenomegaly is a marker of advanced chronic liver disease and portal hypertension in HIV infection. HIV Med. 2022; 24(3):366-371. DOI: 10.1111/hiv.13390. View

Soy M, Atagunduz P, Atagunduz I, Sucak G . Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic. Rheumatol Int. 2020; 41(1):7-18. PMC: 7315691. DOI: 10.1007/s00296-020-04636-y. View

Batur A, Kilincer A, Ates F, Demir N, Ergun R . Evaluation of systemic involvement of Coronavirus disease 2019 through spleen; size and texture analysis. Turk J Med Sci. 2021; 51(3):972-980. PMC: 8283514. DOI: 10.3906/sag-2009-270. View

Tahtabasi M, Hosbul T, Karaman E, Akin Y, Konukoglu O, Sahiner F . Does COVID-19 cause an increase in spleen dimensions? Possible effects of immune activation, hematopoietic suppression and microthrombosis. Clin Imaging. 2021; 79:104-109. PMC: 8080509. DOI: 10.1016/j.clinimag.2021.04.035. View

Balasubramaniam S, Raju B, Perumpallipatty Kumarasamy S, Ramasubramanian S, Srinivasan A, Gopinath I . Lung Involvement Patterns in COVID-19: CT Scan Insights and Prognostic Implications From a Tertiary Care Center in Southern India. Cureus. 2024; 16(1):e53335. PMC: 10907113. DOI: 10.7759/cureus.53335. View

10.

Hakim N, Chi J, Olazagasti C, Liu J . Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients. Exp Biol Med (Maywood). 2020; 246(1):5-9. PMC: 7797996. DOI: 10.1177/1535370220962043. View

11.

Morrissette K, Bridwell R, Lentz S, Brem E, Olmedo Gutierrez K, Singh M . Hemophagocytic Lymphohistiocytosis in the Emergency Department: Recognizing and Evaluating a Hidden Threat. J Emerg Med. 2021; 60(6):743-751. PMC: 7972988. DOI: 10.1016/j.jemermed.2021.02.006. View

12.

Arshad K, Sheikh S, Naqvi S, Sarwar I, Javaid S, Asghar M . FREQUENCY OF SPLENOMEGALY IN DENGUE FEVER IN CHILDREN. J Ayub Med Coll Abbottabad. 2015; 27(2):356-9. View

13.

Sano H, Murakami K, Yokoyama H, Suzuki C, Iwasaki Y, Kodama E . COVID-19 in a Hairy Cell Leukemia Patient: A Rare Case Report. Tohoku J Exp Med. 2022; 258(1):63-68. DOI: 10.1620/tjem.2022.J058. View

14.

Prakash S, Kinder K, Brown K . Spleen size change after hepatitis C treatment: a simple parameter to predict clinical outcomes. J Investig Med. 2023; 71(6):603-612. DOI: 10.1177/10815589231171403. View